tiprankstipranks
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market

Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

949 Followers
See the Price Targets and Ratings of:

PRAX Analyst Ratings

Strong Buy
15Ratings
Strong Buy
13 Buy
1 Hold
1 Sell
Based on 15 analysts giving stock ratings to
Praxis
Precision Medicines
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PRAX Stock 12 Month Forecast

Average Price Target

$608.80
▲(98.51% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Praxis Precision Medicines in the last 3 months. The average price target is $608.80 with a high forecast of $1,245.00 and a low forecast of $130.00. The average price target represents a 98.51% change from the last price of $306.69.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"34":"$34","337":"$337","640":"$640","943":"$943","1246":"$1,246"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1245,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.25K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":608.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$608.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":130,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$130.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[34,337,640,943,1246],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,319.28,390.48923076923074,461.6984615384615,532.9076923076923,604.1169230769231,675.3261538461538,746.5353846153846,817.7446153846154,888.9538461538461,960.1630769230769,1031.3723076923077,1102.5815384615385,1173.7907692307692,{"y":1245,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,319.28,341.5507692307692,363.8215384615384,386.09230769230766,408.3630769230769,430.6338461538461,452.90461538461534,475.1753846153846,497.44615384615383,519.716923076923,541.9876923076922,564.2584615384615,586.5292307692307,{"y":608.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,319.28,304.71999999999997,290.15999999999997,275.59999999999997,261.03999999999996,246.47999999999996,231.92,217.35999999999999,202.79999999999998,188.23999999999998,173.67999999999998,159.11999999999998,144.56,{"y":130,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.06,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.17,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.94,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 45, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":309.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,245Average Price Target$608.80Lowest Price Target$130.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on PRAX
H.C. Wainwright
H.C. Wainwright
$1,245
Buy
305.95%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG), Caribou Biosciences (NASDAQ: CRBU) and Praxis Precision Medicines (NASDAQ: PRAX)
Needham Analyst forecast on PRAX
Needham
Needham
$510
Buy
66.29%
Upside
Reiterated
04/06/26
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (NASDAQ: PDSB), Eli Lilly & Co (NYSE: LLY) and Praxis Precision Medicines (NASDAQ: PRAX)
Wolfe Research Analyst forecast on PRAX
Wolfe Research
Wolfe Research
$500
Buy
63.03%
Upside
Reiterated
04/06/26
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
LifeSci Capital Analyst forecast on PRAX
LifeSci Capital
LifeSci Capital
$534
Buy
74.12%
Upside
Reiterated
04/06/26
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
Guggenheim Analyst forecast on PRAX
Guggenheim
Guggenheim
$800
Buy
160.85%
Upside
Reiterated
03/31/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), PepGen Inc. (NASDAQ: PEPG) and Omeros (NASDAQ: OMER)
Jefferies Analyst forecast on PRAX
Jefferies
Jefferies
$525
Buy
71.18%
Upside
Reiterated
03/31/26
Jefferies Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Truist Financial Analyst forecast on PRAX
Truist Financial
Truist Financial
$700
Buy
128.24%
Upside
Reiterated
03/12/26
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), BillionToOne, Inc. Class A (NASDAQ: BLLN) and Praxis Precision Medicines (NASDAQ: PRAX)
TD Cowen Analyst forecast on PRAX
TD Cowen
TD Cowen
$554
Buy
80.64%
Upside
Reiterated
03/10/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), Biohaven Ltd. (NYSE: BHVN) and Siemens Healthineers AG (Other OTC: SEMHF)
Wedbush
$95$130
Sell
-57.61%
Downside
Reiterated
02/20/26
Analysts Conflicted on These Healthcare Names: US Physical Therapy (NYSE: USPH), Travere Therapeutics (NASDAQ: TVTX) and Praxis Precision Medicines (NASDAQ: PRAX)
JonesTrading Analyst forecast on PRAX
JonesTrading
JonesTrading
$441
Buy
43.79%
Upside
Reiterated
02/20/26
JonesTrading Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Deutsche Bank  Analyst forecast on PRAX
Deutsche Bank
Deutsche Bank
$357$412
Buy
34.34%
Upside
Reiterated
02/20/26
Praxis Precision price target raised to $412 from $357 at Deutsche BankPraxis Precision price target raised to $412 from $357 at Deutsche Bank
Wells Fargo Analyst forecast on PRAX
Wells Fargo
Wells Fargo
$282$305
Hold
-0.55%
Downside
Reiterated
02/20/26
Praxis Precision price target raised to $305 from $282 at Wells FargoPraxis Precision price target raised to $305 from $282 at Wells Fargo
Robert W. Baird Analyst forecast on PRAX
Robert W. Baird
Robert W. Baird
$275$433
Buy
41.18%
Upside
Reiterated
02/20/26
Praxis Precision price target raised to $433 from $275 at BairdPraxis Precision price target raised to $433 from $275 at Baird
BTIG
$843
Buy
174.87%
Upside
Reiterated
02/19/26
BTIG Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)
Piper Sandler Analyst forecast on PRAX
Piper Sandler
Piper Sandler
$450$1,200
Buy
291.27%
Upside
Reiterated
01/28/26
Praxis Precision price target raised to $1,200 from $450 at Piper SandlerPraxis Precision price target raised to $1,200 from $450 at Piper Sandler
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on PRAX
H.C. Wainwright
H.C. Wainwright
$1,245
Buy
305.95%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG), Caribou Biosciences (NASDAQ: CRBU) and Praxis Precision Medicines (NASDAQ: PRAX)
Needham Analyst forecast on PRAX
Needham
Needham
$510
Buy
66.29%
Upside
Reiterated
04/06/26
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (NASDAQ: PDSB), Eli Lilly & Co (NYSE: LLY) and Praxis Precision Medicines (NASDAQ: PRAX)
Wolfe Research Analyst forecast on PRAX
Wolfe Research
Wolfe Research
$500
Buy
63.03%
Upside
Reiterated
04/06/26
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
LifeSci Capital Analyst forecast on PRAX
LifeSci Capital
LifeSci Capital
$534
Buy
74.12%
Upside
Reiterated
04/06/26
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
Guggenheim Analyst forecast on PRAX
Guggenheim
Guggenheim
$800
Buy
160.85%
Upside
Reiterated
03/31/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), PepGen Inc. (NASDAQ: PEPG) and Omeros (NASDAQ: OMER)
Jefferies Analyst forecast on PRAX
Jefferies
Jefferies
$525
Buy
71.18%
Upside
Reiterated
03/31/26
Jefferies Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Truist Financial Analyst forecast on PRAX
Truist Financial
Truist Financial
$700
Buy
128.24%
Upside
Reiterated
03/12/26
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), BillionToOne, Inc. Class A (NASDAQ: BLLN) and Praxis Precision Medicines (NASDAQ: PRAX)
TD Cowen Analyst forecast on PRAX
TD Cowen
TD Cowen
$554
Buy
80.64%
Upside
Reiterated
03/10/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), Biohaven Ltd. (NYSE: BHVN) and Siemens Healthineers AG (Other OTC: SEMHF)
Wedbush
$95$130
Sell
-57.61%
Downside
Reiterated
02/20/26
Analysts Conflicted on These Healthcare Names: US Physical Therapy (NYSE: USPH), Travere Therapeutics (NASDAQ: TVTX) and Praxis Precision Medicines (NASDAQ: PRAX)
JonesTrading Analyst forecast on PRAX
JonesTrading
JonesTrading
$441
Buy
43.79%
Upside
Reiterated
02/20/26
JonesTrading Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Deutsche Bank  Analyst forecast on PRAX
Deutsche Bank
Deutsche Bank
$357$412
Buy
34.34%
Upside
Reiterated
02/20/26
Praxis Precision price target raised to $412 from $357 at Deutsche BankPraxis Precision price target raised to $412 from $357 at Deutsche Bank
Wells Fargo Analyst forecast on PRAX
Wells Fargo
Wells Fargo
$282$305
Hold
-0.55%
Downside
Reiterated
02/20/26
Praxis Precision price target raised to $305 from $282 at Wells FargoPraxis Precision price target raised to $305 from $282 at Wells Fargo
Robert W. Baird Analyst forecast on PRAX
Robert W. Baird
Robert W. Baird
$275$433
Buy
41.18%
Upside
Reiterated
02/20/26
Praxis Precision price target raised to $433 from $275 at BairdPraxis Precision price target raised to $433 from $275 at Baird
BTIG
$843
Buy
174.87%
Upside
Reiterated
02/19/26
BTIG Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)
Piper Sandler Analyst forecast on PRAX
Piper Sandler
Piper Sandler
$450$1,200
Buy
291.27%
Upside
Reiterated
01/28/26
Praxis Precision price target raised to $1,200 from $450 at Piper SandlerPraxis Precision price target raised to $1,200 from $450 at Piper Sandler
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Praxis Precision Medicines

3 Months
xxx
Success Rate
13/16 ratings generated profit
81%
Average Return
+72.54%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 81.25% of your transactions generating a profit, with an average return of +72.54% per trade.
1 Year
Ami FadiaNeedham
Success Rate
13/16 ratings generated profit
81%
Average Return
+278.12%
reiterated a buy rating 3 days ago
Copying Ami Fadia's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +278.12% per trade.
2 Years
xxx
Success Rate
25/26 ratings generated profit
96%
Average Return
+382.65%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 96.15% of your transactions generating a profit, with an average return of +382.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRAX Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
32
27
30
23
19
Buy
28
29
25
14
9
Hold
45
40
26
32
27
Sell
0
0
0
0
0
Strong Sell
1
2
3
2
1
total
106
98
84
71
56
In the current month, PRAX has received 28 Buy Ratings, 27 Hold Ratings, and 1 Sell Ratings. PRAX average Analyst price target in the past 3 months is 608.80.
Each month's total comprises the sum of three months' worth of ratings.

PRAX Financial Forecast

PRAX Earnings Forecast

Next quarter’s earnings estimate for PRAX is -$3.60 with a range of -$5.23 to -$2.87. The previous quarter’s EPS was -$3.50. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.
Next quarter’s earnings estimate for PRAX is -$3.60 with a range of -$5.23 to -$2.87. The previous quarter’s EPS was -$3.50. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Sales Forecast

Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.
Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Stock Forecast FAQ

What is PRAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Praxis Precision Medicines’s 12-month average price target is 608.80.
    What is PRAX’s upside potential, based on the analysts’ average price target?
    Praxis Precision Medicines has 98.51% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PRAX a Buy, Sell or Hold?
          Praxis Precision Medicines has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Praxis Precision Medicines’s price target?
            The average price target for Praxis Precision Medicines is 608.80. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,245.00 ,the lowest forecast is $130.00. The average price target represents 98.51% Increase from the current price of $306.69.
              What do analysts say about Praxis Precision Medicines?
              Praxis Precision Medicines’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of PRAX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.